Eisai Completes Submission of LEQEMBI (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA Eisai Apr 01, 2024 08:39 HKT/SGT Read More
Eisai to Divest Rights for Merislon and Myonal in Japan to Kaken Pharmaceutical Eisai Mar 29, 2024 14:51 HKT/SGT Read More
Eisai's Brain Health Self-Check Tool "NouKNOW" is Certified as "ME-BYO BRAND" by Kanagawa Prefecture Eisai Mar 29, 2024 14:19 HKT/SGT Read More
Eisai: Discovery Research on Dual Orexin Receptor Antagonist Lemborexant Honored with PSJ Award for Drug Research and Development 2024 Eisai Mar 29, 2024 13:32 HKT/SGT Read More
Sino Biopharm (1177.HK) Announces 2023 Annual Results Sino Biopharmaceutical Limited Mar 29, 2024 11:45 HKT/SGT Read More
Avance Clinical은 세계 백신 대회에서 최신 백신 임상시험 뉴스를 공유합니다. 이 중에는 HIV-1 연구도 포함됩니다 Avance Clinical Mar 29, 2024 06:42 HKT/SGT Read More
Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 Study Avance Clinical Mar 28, 2024 14:42 HKT/SGT Read More
China Medical System (867.HK) 2023 Annual Results: Despite of the Temporary Financial Performance Pressure, Fresh Catalysts Emerged from Successive Innovation Breakthroughs China Medical System Holdings Ltd. Mar 28, 2024 11:29 JST Read More
China Medical System (867.HK) 2023 Annual Results: Despite of the Temporary Financial Performance Pressure, Fresh Catalysts Emerged from Successive Innovation Breakthroughs China Medical System Holdings Ltd. Mar 28, 2024 10:23 HKT/SGT Read More
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy System Olympus Mar 27, 2024 14:00 HKT/SGT Read More
AIM submitted pre-application for human diploid rabies vaccine AIM Vaccine Co., Ltd. Mar 27, 2024 12:20 HKT/SGT Read More
Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine Moderna, Inc Mar 26, 2024 19:00 HKT/SGT Read More